Category: Endoscopic / Arthroscopic
Endoscopic / Arthroscopic
An FDA advisory panel unanimously declares endoscopes unsafe, but splits over what to do about the devices, which have been implicated in scores of so-called 'superbug' infections.
An FDA advisory panel last week declared that duodenoscopes, linked to sometimes lethal antibacterial-resistant outbreaks across the U.S., are unsafe as designed.
The panel urged the FDA to act on this information, but didn't ask for a halt to further use of the devices.
A Seattle hospital joins a lawsuit filed against Olympus over the endoscope it makes that's been linked to a spate of fatal 'superbug' infections.
UPDATED May 12, 2015, with comment from Olympus.
Endoscope maker EndoChoice, fresh off a $57 million funding round, registers for an initial public offering worth $115 million.
EndoChoice said today that it filed for an initial public offering that could fetch as much as $115 million, scarcely 2 months after pulling down a $57 million funding round for its Fuse full-spectrum endoscope.
Boston Scientific says it bought a stake in Frankenman Medical, a Chinese medical device maker, with which it plans to build an endoscopy business in China.
Olympus issues an urgent safety advisory on cleaning the endoscopes implicated in lethal 'superbug' outbreaks across the country.
Olympus faces another lawsuit over a 'superbug' infection allegedly caused by 1 of its endoscopes.
A patient infected with a drug-resistant 'superbug' at a Los Angeles hospital sues Olympus, the maker of the endoscope that allegedly caused the infection.
(Reuters) — A 76-year-old man infected with a drug-resistant "superbug" at a Los Angeles hospital has sued the manufacturer of a medical device that allegedly caused the illness in the 5th lawsuit related to the bacterial outbreak at the facility, his attorney said yesterday.